News Headline Summary

WellPoint approves Sequenom's (SQNM) MaterniT21 test for DNA prenatal screening calling it medically necessary

Reaction details (14:49)

- Co. shares move 3.19% higher in immediate reaction to the news from USD 4.70 to USD 4.85.

19 Dec 2012 - 14:47 - Equities - Source: B4THESTREET.COM

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: